School of Mathematics and Statistics - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 39
  • Item
    Thumbnail Image
    Psychosocial Well-Being and Functional Outcomes in Youth With Type 1 Diabetes 12 years After Disease Onset
    Northam, EA ; Lin, A ; Finch, S ; Weather, GA ; Cameron, FJ (AMER DIABETES ASSOC, 2010-07)
    OBJECTIVE: Type 1 diabetes in youth and community controls were compared on functional outcomes. Relationships were examined between psychosocial variables at diagnosis and functional outcome 12 years later. RESEARCH DESIGN AND METHODS: Participants were subjects with type 1 diabetes (n = 110, mean age 20.7 years, SD 4.3) and control subjects (n = 76, mean age 20.8 years, SD 4.0). The measures used included the Youth Self-Report and Young Adult Self-Report and a semi-structured interview of functional outcomes. Type 1 diabetes participants also provided information about current diabetes care and metabolic control from diagnosis. RESULTS: Type 1 diabetes participants and control subjects reported similar levels of current well-being but for the youth with type 1 diabetes, the mental health referral rates over the previous 12 years were higher by 19% and school completion rates were lower by 17%. Over one-third of clinical participants were not currently receiving specialist care and this group had higher mental health service usage in the past (61 vs. 33%) and lower current psychosocial well- being. Within the type 1 diabetes group, behavior problems, high activity, and low family cohesion at diagnosis predicted lower current well-being, but were not associated with metabolic control history. Poorer metabolic control was associated with higher mental health service usage. CONCLUSIONS: Type 1 diabetes participants report similar levels of current psychosocial well-being compared with control subjects, but higher levels of psychiatric morbidity since diagnosis and lower school completion rates. Psychiatric morbidity was associated with poor metabolic control and failure to transition to tertiary adult diabetes care.
  • Item
    No Preview Available
    Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
    Craddock, N ; Hurles, ME ; Cardin, N ; Pearson, RD ; Plagnol, V ; Robson, S ; Vukcevic, D ; Barnes, C ; Conrad, DF ; Giannoulatou, E ; Holmes, C ; Marchini, JL ; Stirrups, K ; Tobin, MD ; Wain, LV ; Yau, C ; Aerts, J ; Ahmad, T ; Andrews, TD ; Arbury, H ; Attwood, A ; Auton, A ; Ball, SG ; Balmforth, AJ ; Barrett, JC ; Barroso, I ; Barton, A ; Bennett, AJ ; Bhaskar, S ; Blaszczyk, K ; Bowes, J ; Brand, OJ ; Braund, PS ; Bredin, F ; Breen, G ; Brown, MJ ; Bruce, IN ; Bull, J ; Burren, OS ; Burton, J ; Byrnes, J ; Caesar, S ; Clee, CM ; Coffey, AJ ; Connell, JMC ; Cooper, JD ; Dominiczak, AF ; Downes, K ; Drummond, HE ; Dudakia, D ; Dunham, A ; Ebbs, B ; Eccles, D ; Edkins, S ; Edwards, C ; Elliot, A ; Emery, P ; Evans, DM ; Evans, G ; Eyre, S ; Farmer, A ; Ferrier, IN ; Feuk, L ; Fitzgerald, T ; Flynn, E ; Forbes, A ; Forty, L ; Franklyn, JA ; Freathy, RM ; Gibbs, P ; Gilbert, P ; Gokumen, O ; Gordon-Smith, K ; Gray, E ; Green, E ; Groves, CJ ; Grozeva, D ; Gwilliam, R ; Hall, A ; Hammond, N ; Hardy, M ; Harrison, P ; Hassanali, N ; Hebaishi, H ; Hines, S ; Hinks, A ; Hitman, GA ; Hocking, L ; Howard, E ; Howard, P ; Howson, JMM ; Hughes, D ; Hunt, S ; Isaacs, JD ; Jain, M ; Jewell, DP ; Johnson, T ; Jolley, JD ; Jones, IR ; Jones, LA ; Kirov, G ; Langford, CF ; Lango-Allen, H ; Lathrop, GM ; Lee, J ; Lee, KL ; Lees, C ; Lewis, K ; Lindgren, CM ; Maisuria-Armer, M ; Maller, J ; Mansfield, J ; Martin, P ; Massey, DCO ; McArdle, WL ; McGuffin, P ; McLay, KE ; Mentzer, A ; Mimmack, ML ; Morgan, AE ; Morris, AP ; Mowat, C ; Myers, S ; Newman, W ; Nimmo, ER ; O'Donovan, MC ; Onipinla, A ; Onyiah, I ; Ovington, NR ; Owen, MJ ; Palin, K ; Parnell, K ; Pernet, D ; Perry, JRB ; Phillips, A ; Pinto, D ; Prescott, NJ ; Prokopenko, I ; Quail, MA ; Rafelt, S ; Rayner, NW ; Redon, R ; Reid, DM ; Renwick, A ; Ring, SM ; Robertson, N ; Russell, E ; St Clair, D ; Sambrook, JG ; Sanderson, JD ; Schuilenburg, H ; Scott, CE ; Scott, R ; Seal, S ; Shaw-Hawkins, S ; Shields, BM ; Simmonds, MJ ; Smyth, DJ ; Somaskantharajah, E ; Spanova, K ; Steer, S ; Stephens, J ; Stevens, HE ; Stone, MA ; Su, Z ; Symmons, DPM ; Thompson, JR ; Thomson, W ; Travers, ME ; Turnbull, C ; Valsesia, A ; Walker, M ; Walker, NM ; Wallace, C ; Warren-Perry, M ; Watkins, NA ; Webster, J ; Weedon, MN ; Wilson, AG ; Woodburn, M ; Wordsworth, BP ; Young, AH ; Zeggini, E ; Carter, NP ; Frayling, TM ; Lee, C ; McVean, G ; Munroe, PB ; Palotie, A ; Sawcer, SJ ; Scherer, SW ; Strachan, DP ; Tyler-Smith, C ; Brown, MA ; Burton, PR ; Caulfield, MJ ; Compston, A ; Farrall, M ; Gough, SCL ; Hall, AS ; Hattersley, AT ; Hill, AVS ; Mathew, CG ; Pembrey, M ; Satsangi, J ; Stratton, MR ; Worthington, J ; Deloukas, P ; Duncanson, A ; Kwiatkowski, DP ; McCarthy, MI ; Ouwehand, WH ; Parkes, M ; Rahman, N ; Todd, JA ; Samani, NJ ; Donnelly, P (NATURE PORTFOLIO, 2010-04-01)
    Copy number variants (CNVs) account for a major proportion of human genetic polymorphism and have been predicted to have an important role in genetic susceptibility to common disease. To address this we undertook a large, direct genome-wide study of association between CNVs and eight common human diseases. Using a purpose-designed array we typed approximately 19,000 individuals into distinct copy-number classes at 3,432 polymorphic CNVs, including an estimated approximately 50% of all common CNVs larger than 500 base pairs. We identified several biological artefacts that lead to false-positive associations, including systematic CNV differences between DNAs derived from blood and cell lines. Association testing and follow-up replication analyses confirmed three loci where CNVs were associated with disease-IRGM for Crohn's disease, HLA for Crohn's disease, rheumatoid arthritis and type 1 diabetes, and TSPAN8 for type 2 diabetes-although in each case the locus had previously been identified in single nucleotide polymorphism (SNP)-based studies, reflecting our observation that most common CNVs that are well-typed on our array are well tagged by SNPs and so have been indirectly explored through SNP studies. We conclude that common CNVs that can be typed on existing platforms are unlikely to contribute greatly to the genetic basis of common human diseases.
  • Item
    No Preview Available
    International network of cancer genome projects
    Hudson, TJ ; Anderson, W ; Aretz, A ; Barker, AD ; Bell, C ; Bernabe, RR ; Bhan, MK ; Calvo, F ; Eerola, I ; Gerhard, DS ; Guttmacher, A ; Guyer, M ; Hemsley, FM ; Jennings, JL ; Kerr, D ; Klatt, P ; Kolar, P ; Kusuda, J ; Lane, DP ; Laplace, F ; Lu, Y ; Nettekoven, G ; Ozenberger, B ; Peterson, J ; Rao, TS ; Remacle, J ; Schafer, AJ ; Shibata, T ; Stratton, MR ; Vockley, JG ; Watanabe, K ; Yang, H ; Yuen, MMF ; Knoppers, M ; Bobrow, M ; Cambon-Thomsen, A ; Dressler, LG ; Dyke, SOM ; Joly, Y ; Kato, K ; Kennedy, KL ; Nicolas, P ; Parker, MJ ; Rial-Sebbag, E ; Romeo-Casabona, CM ; Shaw, KM ; Wallace, S ; Wiesner, GL ; Zeps, N ; Lichter, P ; Biankin, AV ; Chabannon, C ; Chin, L ; Clement, B ; de Alava, E ; Degos, F ; Ferguson, ML ; Geary, P ; Hayes, DN ; Johns, AL ; Nakagawa, H ; Penny, R ; Piris, MA ; Sarin, R ; Scarpa, A ; van de Vijver, M ; Futreal, PA ; Aburatani, H ; Bayes, M ; Bowtell, DDL ; Campbell, PJ ; Estivill, X ; Grimmond, SM ; Gut, I ; Hirst, M ; Lopez-Otin, C ; Majumder, P ; Marra, M ; Ning, Z ; Puente, XS ; Ruan, Y ; Stunnenberg, HG ; Swerdlow, H ; Velculescu, VE ; Wilson, RK ; Xue, HH ; Yang, L ; Spellman, PT ; Bader, GD ; Boutros, PC ; Flicek, P ; Getz, G ; Guigo, R ; Guo, G ; Haussler, D ; Heath, S ; Hubbard, TJ ; Jiang, T ; Jones, SM ; Li, Q ; Lopez-Bigas, N ; Luo, R ; Pearson, JV ; Quesada, V ; Raphael, BJ ; Sander, C ; Speed, TP ; Stuart, JM ; Teague, JW ; Totoki, Y ; Tsunoda, T ; Valencia, A ; Wheeler, DA ; Wu, H ; Zhao, S ; Zhou, G ; Stein, LD ; Lathrop, M ; Ouellette, BFF ; Thomas, G ; Yoshida, T ; Axton, M ; Gunter, C ; McPherson, JD ; Miller, LJ ; Kasprzyk, A ; Zhang, J ; Haider, SA ; Wang, J ; Yung, CK ; Cross, A ; Liang, Y ; Gnaneshan, S ; Guberman, J ; Hsu, J ; Chalmers, DRC ; Hasel, KW ; Kaan, TSH ; Knoppers, BM ; Lowrance, WW ; Masui, T ; Rodriguez, LL ; Vergely, C ; Cloonan, N ; Defazio, A ; Eshleman, JR ; Etemadmoghadam, D ; Gardiner, BA ; Kench, JG ; Sutherland, RL ; Tempero, MA ; Waddell, NJ ; Wilson, PJ ; Gallinger, S ; Tsao, M-S ; Shaw, PA ; Petersen, GM ; Mukhopadhyay, D ; DePinho, RA ; Thayer, S ; Muthuswamy, L ; Shazand, K ; Beck, T ; Sam, M ; Timms, L ; Ballin, V ; Ji, J ; Zhang, X ; Chen, F ; Hu, X ; Yang, Q ; Tian, G ; Zhang, L ; Xing, X ; Li, X ; Zhu, Z ; Yu, Y ; Yu, J ; Tost, J ; Brennan, P ; Holcatova, I ; Zaridze, D ; Brazma, A ; Egevad, L ; Prokhortchouk, E ; Banks, RE ; Uhlen, M ; Viksna, J ; Ponten, F ; Skryabin, K ; Birney, E ; Borg, A ; Borresen-Dale, A-L ; Caldas, C ; Foekens, JA ; Martin, S ; Reis-Filho, JS ; Richardson, AL ; Sotiriou, C ; van't Veer, L ; Birnbaum, D ; Blanche, H ; Boucher, P ; Boyault, S ; Masson-Jacquemier, JD ; Pauporte, I ; Pivot, X ; Vincent-Salomon, A ; Tabone, E ; Theillet, C ; Treilleux, I ; Bioulac-Sage, P ; Decaens, T ; Franco, D ; Gut, M ; Samuel, D ; Zucman-Rossi, J ; Eils, R ; Brors, B ; Korbel, JO ; Korshunov, A ; Landgraf, P ; Lehrach, H ; Pfister, S ; Radlwimmer, B ; Reifenberger, G ; Taylor, MD ; von Kalle, C ; Majumder, PP ; Pederzoli, P ; Lawlor, RT ; Delledonne, M ; Bardelli, A ; Gress, T ; Klimstra, D ; Zamboni, G ; Nakamura, Y ; Miyano, S ; Fujimoto, A ; Campo, E ; de Sanjose, S ; Montserrat, E ; Gonzalez-Diaz, M ; Jares, P ; Himmelbaue, H ; Bea, S ; Aparicio, S ; Easton, DF ; Collins, FS ; Compton, CC ; Lander, ES ; Burke, W ; Green, AR ; Hamilton, SR ; Kallioniemi, OP ; Ley, TJ ; Liu, ET ; Wainwright, BJ (NATURE PORTFOLIO, 2010-04-15)
    The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
  • Item
    Thumbnail Image
    A Bayesian Search for Transcriptional Motifs
    Miller, AK ; Print, CG ; Nielsen, PMF ; Crampin, EJ ; Di Bernardo, D (PUBLIC LIBRARY SCIENCE, 2010-11-18)
    Identifying transcription factor (TF) binding sites (TFBSs) is an important step towards understanding transcriptional regulation. A common approach is to use gaplessly aligned, experimentally supported TFBSs for a particular TF, and algorithmically search for more occurrences of the same TFBSs. The largest publicly available databases of TF binding specificities contain models which are represented as position weight matrices (PWM). There are other methods using more sophisticated representations, but these have more limited databases, or aren't publicly available. Therefore, this paper focuses on methods that search using one PWM per TF. An algorithm, MATCHTM, for identifying TFBSs corresponding to a particular PWM is available, but is not based on a rigorous statistical model of TF binding, making it difficult to interpret or adjust the parameters and output of the algorithm. Furthermore, there is no public description of the algorithm sufficient to exactly reproduce it. Another algorithm, MAST, computes a p-value for the presence of a TFBS using true probabilities of finding each base at each offset from that position. We developed a statistical model, BaSeTraM, for the binding of TFs to TFBSs, taking into account random variation in the base present at each position within a TFBS. Treating the counts in the matrices and the sequences of sites as random variables, we combine this TFBS composition model with a background model to obtain a Bayesian classifier. We implemented our classifier in a package (SBaSeTraM). We tested SBaSeTraM against a MATCHTM implementation by searching all probes used in an experimental Saccharomyces cerevisiae TF binding dataset, and comparing our predictions to the data. We found no statistically significant differences in sensitivity between the algorithms (at fixed selectivity), indicating that SBaSeTraM's performance is at least comparable to the leading currently available algorithm. Our software is freely available at: http://wiki.github.com/A1kmm/sbasetram/building-the-tools.
  • Item
    Thumbnail Image
    Gene Network Disruptions and Neurogenesis Defects in the Adult Ts1Cje Mouse Model of Down Syndrome
    Hewitt, CA ; Ling, K-H ; Merson, TD ; Simpson, KM ; Ritchie, ME ; King, SL ; Pritchard, MA ; Smyth, GK ; Thomas, T ; Scott, HS ; Voss, AK ; Aziz, SA (PUBLIC LIBRARY SCIENCE, 2010-07-16)
    BACKGROUND: Down syndrome (DS) individuals suffer mental retardation with further cognitive decline and early onset Alzheimer's disease. METHODOLOGY/PRINCIPAL FINDINGS: To understand how trisomy 21 causes these neurological abnormalities we investigated changes in gene expression networks combined with a systematic cell lineage analysis of adult neurogenesis using the Ts1Cje mouse model of DS. We demonstrated down regulation of a number of key genes involved in proliferation and cell cycle progression including Mcm7, Brca2, Prim1, Cenpo and Aurka in trisomic neurospheres. We found that trisomy did not affect the number of adult neural stem cells but resulted in reduced numbers of neural progenitors and neuroblasts. Analysis of differentiating adult Ts1Cje neural progenitors showed a severe reduction in numbers of neurons produced with a tendency for less elaborate neurites, whilst the numbers of astrocytes was increased. CONCLUSIONS/SIGNIFICANCE: We have shown that trisomy affects a number of elements of adult neurogenesis likely to result in a progressive pathogenesis and consequently providing the potential for the development of therapies to slow progression of, or even ameliorate the neuronal deficits suffered by DS individuals.
  • Item
    Thumbnail Image
    Growth patterns in Onychophora (velvet worms): lack of a localised posterior proliferation zone
    Mayer, G ; Kato, C ; Quast, B ; Chisholm, RH ; Landman, KA ; Quinn, LM (BMC, 2010-11-04)
    BACKGROUND: During embryonic development of segmented animals, body segments are thought to arise from the so-called "posterior growth zone" and the occurrence of this "zone" has been used to support the homology of segmentation between arthropods, annelids, and vertebrates. However, the term "posterior growth zone" is used ambiguously in the literature, mostly referring to a region of increased proliferation at the posterior end of the embryo. To determine whether such a localised posterior proliferation zone is an ancestral feature of Panarthropoda (Onychophora + Tardigrada + Arthropoda), we examined cell division patterns in embryos of Onychophora. RESULTS: Using in vivo incorporation of the DNA replication marker BrdU (5-bromo-2'-deoxyuridine) and anti-phospho-histone H3 immunolabelling, we found that a localised posterior region of proliferating cells does not occur at any developmental stage in onychophoran embryos. This contrasts with a localised pattern of cell divisions at the posterior end of annelid embryos, which we used as a positive control. Based on our data, we present a mathematical model, which challenges the paradigm that a localised posterior proliferation zone is necessary for segment patterning in short germ developing arthropods. CONCLUSIONS: Our findings suggest that a posterior proliferation zone was absent in the last common ancestor of Onychophora and Arthropoda. By comparing our data from Onychophora with those from annelids, arthropods, and chordates, we suggest that the occurrence of a "posterior growth zone" currently cannot be used to support the homology of segmentation between these three animal groups.
  • Item
    Thumbnail Image
    Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9
    Mathews, JD ; McBryde, ES ; McVernon, J ; Pallaghy, PK ; McCaw, JM (BMC, 2010-05-25)
    BACKGROUND: The ecology of influenza may be more complex than is usually assumed. For example, despite multiple waves in the influenza pandemic of 1918-19, many people in urban locations were apparently unaffected. Were they unexposed, or protected by pre-existing cross-immunity in the first wave, by acquired immunity in later waves, or were their infections asymptomatic? METHODS: We modelled all these possibilities to estimate parameters to best explain patterns of repeat attacks in 24,706 individuals potentially exposed to summer, autumn and winter waves in 12 English populations during the 1918-9 pandemic. RESULTS: Before the summer wave, we estimated that only 52% of persons (95% credibility estimates 41-66%) were susceptible, with the remainder protected by prior immunity. Most people were exposed, as virus transmissibility was high with R0 credibility estimates of 3.10-6.74. Because of prior immunity, estimates of effective R at the start of the summer wave were lower at 1.57-3.96. Only 25-66% of exposed and susceptible persons reported symptoms. After each wave, 33-65% of protected persons became susceptible again before the next wave through waning immunity or antigenic drift. Estimated rates of prior immunity were less in younger populations (19-59%) than in adult populations (38-66%), and tended to lapse more frequently in the young (49-92%) than in adults (34-76%). CONCLUSIONS: Our model for pandemic influenza in 1918-9 suggests that pre-existing immune protection, presumably induced by prior exposure to seasonal influenza, may have limited the pandemic attack-rate in urban populations, while the waning of that protection likely contributed to recurrence of pandemic waves in exposed cities. In contrast, in isolated populations, pandemic attack rates in 1918-9 were much higher than in cities, presumably because prior immunity was less in populations with infrequent prior exposure to seasonal influenza. Although these conclusions cannot be verified by direct measurements of historical immune mechanisms, our modelling inferences from 1918-9 suggest that the spread of the influenza A (H1N1) 2009 pandemic has also been limited by immunity from prior exposure to seasonal influenza. Components of that immunity, which are measurable, may be short-lived, and not necessarily correlated with levels of HI antibody.
  • Item
    Thumbnail Image
    Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
    Gorringe, KL ; George, J ; Anglesio, MS ; Ramakrishna, M ; Etemadmoghadam, D ; Cowin, P ; Sridhar, A ; Williams, LH ; Boyle, SE ; Yanaihara, N ; Okamoto, A ; Urashima, M ; Smyth, GK ; Campbell, IG ; Bowtell, DDL ; Jordan, IK (PUBLIC LIBRARY SCIENCE, 2010-09-10)
    Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, it has been difficult to determine the most relevant copy number alterations with the scale of studies to date. We obtained genome-wide copy number alteration (CNA) data from four different SNP array platforms, with a final data set of 398 ovarian tumours, mostly of the serous histological subtype. Frequent CNA aberrations targeted many thousands of genes. However, high-level amplicons and homozygous deletions enabled filtering of this list to the most relevant. The large data set enabled refinement of minimal regions and identification of rare amplicons such as at 1p34 and 20q11. We performed a novel co-occurrence analysis to assess cooperation and exclusivity of CNAs and analysed their relationship to patient outcome. Positive associations were identified between gains on 19 and 20q, gain of 20q and loss of X, and between several regions of loss, particularly 17q. We found weak correlations of CNA at genomic loci such as 19q12 with clinical outcome. We also assessed genomic instability measures and found a correlation of the number of higher amplitude gains with poorer overall survival. By assembling the largest collection of ovarian copy number data to date, we have been able to identify the most frequent aberrations and their interactions.
  • Item
    Thumbnail Image
    Building a Morphogen Gradient without Diffusion in a Growing Tissue
    Chisholm, RH ; Hughes, BD ; Landman, KA ; Secomb, TW (PUBLIC LIBRARY SCIENCE, 2010-09-30)
    In many developmental systems, spatial pattern arises from morphogen gradients, which provide positional information for cells to determine their fate. Typically, diffusion is thought to be the mechanism responsible for building a morphogen gradient. An alternative mechanism is investigated here. Using mathematical modeling, we demonstrate how a non-diffusive morphogen concentration gradient can develop in axially growing tissue systems, where growth is due to cell proliferation only. Two distinct cases are considered: in the first, all cell proliferation occurs in a localized zone where active transcription of a morphogen-producing gene occurs, and in the second, cell proliferation is uniformly distributed throughout the tissue, occurring in both the active transcription zone and beyond. A cell containing morphogen mRNA produces the morphogen protein, hence any gradient in mRNA transcripts translates into a corresponding morphogen protein gradient. Proliferation-driven growth gives rise to both advection (the transport term) and dilution (a reaction term). These two key mechanisms determine the resultant mRNA transcript distribution. Using the full range of uniform initial conditions, we show that advection and dilution due to cell proliferation are, in general, sufficient for morphogen gradient formation for both types of axially growing systems. In particular, mRNA transcript degradation is not necessary for gradient formation; it is only necessary with localized proliferation for one special value of the initial concentration. Furthermore, the morphogen concentration decreases with distance away from the transcription zone, except in the case of localized proliferation with the initial concentration sufficiently large, when the concentration can either increase with distance from the transcription zone or sustain a local minimum. In both localized and uniformly distributed proliferation, in order for a concentration gradient to form across the whole domain, transcription must occur in a zone equal to the initial domain size; otherwise, it will only form across part of the tissue.
  • Item
    Thumbnail Image
    Mapping of long-range associations throughout the fission yeast genome reveals global genome organization linked to transcriptional regulation
    Tanizawa, H ; Iwasaki, O ; Tanaka, A ; Capizzi, JR ; Wickramasinghe, P ; Lee, M ; Fu, Z ; Noma, K-I (OXFORD UNIV PRESS, 2010-12)
    We have comprehensively mapped long-range associations between chromosomal regions throughout the fission yeast genome using the latest genomics approach that combines next generation sequencing and chromosome conformation capture (3C). Our relatively simple approach, referred to as enrichment of ligation products (ELP), involves digestion of the 3C sample with a 4 bp cutter and self-ligation, achieving a resolution of 20 kb. It recaptures previously characterized genome organizations and also identifies new and important interactions. We have modeled the 3D structure of the entire fission yeast genome and have explored the functional relationships between the global genome organization and transcriptional regulation. We find significant associations among highly transcribed genes. Moreover, we demonstrate that genes co-regulated during the cell cycle tend to associate with one another when activated. Remarkably, functionally defined genes derived from particular gene ontology groups tend to associate in a statistically significant manner. Those significantly associating genes frequently contain the same DNA motifs at their promoter regions, suggesting that potential transcription factors binding to these motifs are involved in defining the associations among those genes. Our study suggests the presence of a global genome organization in fission yeast that is functionally similar to the recently proposed mammalian transcription factory.